Dilation system and method of using the same

Information

  • Patent Grant
  • 11737743
  • Patent Number
    11,737,743
  • Date Filed
    Monday, February 22, 2021
    3 years ago
  • Date Issued
    Tuesday, August 29, 2023
    8 months ago
Abstract
A method of forming an access opening through a psoas muscle to a patient's spine includes laterally inserting a stimulating dilator into the psoas muscle. The stimulating dilator has a stimulation channel formed in an outer surface thereof. An electrical pulse is transmitted into the stimulating dilator to locate a position of a nerve in the patient's psoas muscle. The stimulating dilator is laterally inserted through the psoas muscle and toward the patient's spine in a way that avoids the nerve. A stimulating probe is inserted into the stimulation channel along the outer surface of the stimulating dilator while transmitting an electrical pulse into the stimulating probe to verify the position of the nerve.
Description
BACKGROUND OF THE INVENTION

Generally speaking, sequential dilation systems enable a surgeon to make an initial incision and gradually increase the size of the incision by sequential insertion of increasingly larger dilators. Sequential dilation is preferably able to reduce tissue damage and associated trauma to speed patient recovery time. In addition, dilation is utilized to prepare a surgical path to a surgical site and a stimulator may be utilized with the dilator to direct the dilator along a path that avoids specific areas of the patient's anatomy, such as neural elements or nerves.


SUMMARY OF THE INVENTION

A preferred embodiment of the present invention relates generally to minimally invasive surgical procedures and apparatus and, more particularly, to a dilation system and related methods for directional dilation of an incision for use in creating an access opening to a patient's spine. More specifically, the present invention relates to a dilation system and related methods that are able to laterally access a lumbar region of a patient's spine through the patient's psoas muscle. In accordance with one aspect of the present invention, the neural elements or nerves of the psoas muscle are preferably mapped using a stimulating probe, thereby defining a safe zone of passage. The stimulating probe is inserted through the psoas muscle and toward or into the intervertebral disc space. Directional dilators may be used to dilate the psoas muscle to substantially separate tissue on only one side of the stimulating probe. That is, directional, sequential dilators may be inserted to dilate the psoas muscle, for example, on the anterior side of the stimulating probe while substantially leaving the psoas muscle intact on the posterior side of the stimulating probe. Specifically, the directional, sequential dilators may be utilized to directionally dilate tissue away from a neural element or nerve in the patient's body that is identified by the stimulating probe such that the neural element or nerve is not disturbed or damaged by the dilation process or other surgical procedures that may occur following dilation.


Alternatively, the dilation system and method may include a blunt stimulating dilator including at least one channel formed in an outer surface. The channel receives a stimulating probe that is used to map the neural elements or nerves of the psoas muscle and define a safe zone of passage to the patient's spine. The stimulating dilator is inserted through the psoas muscle and toward or into the intervertebral disc space. A stimulating probe is then inserted into the channel formed in the outer surface of the stimulating dilator in order to verify the neural elements or nerves.





BRIEF DESCRIPTION OF THE DRAWINGS

The foregoing summary, as well as the following detailed description of the preferred embodiments of the application, will be better understood when read in conjunction with the appended drawings. For the purposes of illustrating the dilation system and methods of the present application, there is shown in the drawings preferred embodiments. It should be understood, however, that the application is not limited to the precise arrangements and instrumentalities shown. In the drawings:



FIG. 1 illustrates a side elevational view of a dilation system in accordance with a first preferred embodiment the present invention, which will generally be referred to herein as a directional sequential dilation system;



FIG. 2 illustrates a magnified perspective view of the distal end of the directional sequential dilation system shown in FIG. 1;



FIG. 2A illustrates an exploded view of the distal end of the directional sequential dilation system shown in FIG. 2;



FIG. 3 illustrates a cross-sectional view of the directional sequential dilation system of FIG. 1, taken along line 3-3 of FIG. 1;



FIG. 4 illustrates a front elevational view of the directional sequential dilation system shown in FIG. 1 including a schematic representation of a retractor that may be used in connection with the directional sequential dilation system;



FIG. 5A illustrates a side view of a first directional dilator used in connection with the directional sequential dilation system shown in FIG. 1;



FIG. 5B illustrates a front view of the first directional dilator shown in FIG. 5A;



FIG. 6A illustrates a side view of a second directional dilator used in connection with the directional sequential dilation system shown in FIG. 1;



FIG. 6B illustrates a front view of the second directional dilator shown in FIG. 6A;



FIG. 7 illustrates a side elevational view of a dilation system in accordance with a second preferred embodiment of the present invention, which will generally be referred to herein as a blunt stimulating dilation system;



FIG. 8 illustrates a top plan view of the blunt stimulating dilation system of FIG. 7;



FIG. 9 illustrates a magnified, top perspective view of a proximal end of the blunt stimulating dilation system of FIG. 7;



FIG. 10 illustrates a magnified bottom perspective view of a distal end of the blunt stimulating dilation system of FIG. 7;



FIG. 11 illustrates a top plan view of a dilation system in accordance with a third preferred embodiment of the present invention, which is also comprised of a blunt stimulating dilation system; and



FIG. 12 illustrates a magnified, top perspective view of a proximal end of the blunt stimulating dilation system of FIG. 11.





DETAILED DESCRIPTION OF THE INVENTION

Certain terminology is used in the following description for convenience only and is not limiting. The words “right”, “left”, “top” and “bottom” designate directions in the drawings to which reference is made. The words “inwardly” and “outwardly” refer to directions toward and away from, respectively, the geometric center of the directional sequential and blunt stimulating dilation systems and designated parts thereof. The words, “anterior”, “posterior”, “superior”, “inferior” and related words and/or phrases designate preferred positions and orientations in the human body to which reference is made and are not meant to be limiting. The terminology includes the above-listed words, derivatives thereof and words of similar import.


Certain exemplary embodiments of the invention will now be described with reference to the drawings. In general, such embodiments relate to dilation systems for accessing a patient's spinal column and, preferably, for laterally accessing the lumbar region of the patient's spine.


As generally understood by one of ordinary skill in the art, the dilation systems will be described in connection with accessing the spine to perform a surgical procedure, but the dilation systems will find use not only in orthopedic surgery, but in other surgical procedures in which a surgeon wishes to gain access to an internal cavity by cutting the skin and going through the body wall in order to keep the incision spread apart so that surgical instruments can be inserted. For example, the dilation systems may be used for anteriorly or posteriorly accessing the spine, for accessing the thoracic or cervical region of the spine, or for accessing nearly any other part of the body.


Referring to FIG. 4, generally speaking, during a lateral approach to a patient's spine 2, a psoas muscle 4, which is located on either side of the spine 2, is preferably separated in order to access the spine 2 and, in particular, an intervertebral disc space 6 or one or more vertebral bodies 8 within a patient's spinal column. It is desirable to avoid neural elements or nerves 9 of the lumbar plexus that lie within the psoas muscle 4 during such procedures. The anterior third of the psoas muscle 4 is typically considered a safe zone for muscle separation.


The neural elements or nerves 9 of the psoas muscle 4 are preferably mapped using a stimulating probe 20. In this manner, the most posterior neural or nerve free area of the psoas muscle 4 is preferably located and identified. The stimulating probe 20 may then be inserted through the psoas muscle 4 via the most posterior neural or nerve free tissue area or through nearly any other region that is free of neural elements or nerves 9 and toward the spine 2 or into the intervertebral disc space 6 in order to initiate safe tissue separation of the psoas muscle 4. Directional dilators 30, 40 in accordance with the first preferred embodiment of the present invention may be used to dilate the muscle separation. In particular, the directional dilators 30, 40 may be used to primarily separate tissue on one side of the stimulating probe 20 (shown as cranial side), preferably on the anterior side of the stimulating probe 20 (e.g., the safe zone as initially identified and marked by the stimulating probe 20). That is, by using the directional sequential dilators 30, 40, the tissue on one side of the stimulating probe 20 may be moved while substantially limiting movement of the tissue on the opposite side of the stimulating probe 20. In comparison, concentric dilators separate the muscle radially and, as such, dilate tissue on both sides of the stimulating probe. This in turn may impinge on neural elements or nerves 9 located outside of the safe zone.


Referring to FIGS. 1-6B, a first preferred embodiment of a dilation system of the present invention is comprised of a directional sequential dilation system 10. The directional sequential dilation system 10 preferably includes a stimulating probe 20, a first directional dilator 30 and a second directional dilator 40. The directional sequential dilation system 10 may include more or less dilators such as, for example, one, three, four, etc. The stimulating probe 20 can be any probe now or hereafter known for transmitting an electrical pulse. The stimulating probe 20 preferably includes a probe tip 20a and a longitudinal probe axis 21. The first directional dilator 30 preferably includes a first longitudinal axis 31, an outer surface 32, a proximal end 33, a distal end 34 and a first bore 35 extending from the proximal end 33 to the distal end 34. The first directional dilator 30 also preferably includes a first tip 30a at the distal end 34 through which the first longitudinal axis 31 extends. The first bore 35 has a first bore axis 36 that extends from a proximal end to a distal end of the first bore 35. The first longitudinal axis 36 is preferably offset or located a first offset distance A from the first longitudinal axis 31. The first directional dilator 30 also preferably includes a first channel 38 formed in the outer surface 32 thereof. The first channel 38 is preferably in communication with the first bore 35 along the entire length of the first bore 35. In use, the first bore 35 and the first channel 38 removably receive the stimulating probe 20 in an assembled configuration (e.g., when the stimulating probe 20 is slidably received within the first bore 35 of the first directional dilator 30) so that a surgeon can stimulate the first directional dilator 30. The probe axis 21 of the stimulating probe 20 is preferably coaxial with the first bore axis 36 of the first directional dilator 30 in the assembled configuration.


Similarly, the second directional dilator 40 preferably includes a second longitudinal axis 41, an outer surface 42, a proximal end 43, a distal end 44 and a second bore 45 extending from the proximal end 43 to the distal end 44. The second bore 45 preferably has a second bore axis 46 that extends from the proximal end 43 to the distal end 44. The second directional dilator 40 also preferably includes a second tip 40a at the distal end 44 through which the second longitudinal axis 41 extends. The second bore axis 46 of the second bore 45 is offset or located a second offset distance B from the second longitudinal axis 41. The outer surfaces 32, 42 of the first and second directional dilators 30, 40 are preferably coated to prevent electrical leakage during use, as will be apparent to one having ordinary skill in the art. The second directional dilator 40 also preferably includes a second channel 48 formed in the outer surface 42 thereof that is in communication with the second bore 45. In use, the second bore 45 and the second channel 48 receive the first directional dilator 30 therein in the assembled configuration (e.g., when the first directional dilator 30 is slidably received within the second bore 45 of the second directional dilator 40). The first longitudinal axis 31 of the first directional dilator 30 is preferably coaxial with the second bore axis 46 of the second directional dilator 40 when in the assembled configuration.


Because the first and second bore axes 36, 46 of the first and second bores 35, 45 are offset from the first and second longitudinal axes 31, 41 of the first and second directional dilators 30, 40, respectively, inserting the first directional dilator 30 over the stimulating probe 20 and then the second directional dilator 40 over the first directional dilator 30 causes each sequential dilator to “directionally” dilate the opening formed in the patient preferably away from any neural elements, nerves 9 or other anatomic structure on the opposite side of the stimulating probe 20, as will be described in greater detail below.


Moreover, incorporation of the first and second channels 38, 48 enables the first and second directional dilators 30, 40 to be more closely nested together and thus, substantially eliminate the “cookie cutter” effect that is realized when using multiple concentric dilators of increasing inner bore size.


The first directional dilator 30 preferably includes a plurality of first depth indicators 37 located on the outer surface 32 thereof (as best shown in FIGS. 5A and 5B). The plurality of first depth indicators 37 extend, on the outer surface 32 of the first directional dilator 30, generally perpendicular to the first longitudinal axis 31. The plurality of first depth indicators 37 indicate to the surgeon the various distances between the first tip 30a formed at the distal end 34 of the first directional dilator 30 to the respective depth indicator 37 so that, in use, the surgeon can determine how far the first directional dilator 30 has been inserted into the patient. Similarly, as best shown in FIGS. 6A and 6B, the second directional dilator 40 preferably includes a plurality of second depth indicators 47 located on the outer surface 42 thereof. The plurality of second depth indicators 47 extend, on the outer surface 42 of the second directional dilator 40, generally perpendicular to the second longitudinal axis 41. The plurality of second depth indicators 47 indicate to the surgeon the various distances between the second tip 40a formed at the distal end 44 of the second directional dilator 40 to the respective depth indicator 47 so that, in use, the surgeon can determine how far the second directional dilator 40 has been inserted into the patient. In the first preferred embodiment, the plurality of first and second depth indicators 37, 47 are spaced a distance of eighty millimeters (80 mm) to one hundred fifty millimeters (150 mm) from the first and second tips 30a, 40a in ten millimeter (10 mm) increments. However, the plurality of plurality of first and second depth indicators 37, 47 are not limited to these dimensions and may be spaced from the first and second tips 30a, 40a at nearly any distance or spacing that is preferred by a surgeon and is able to show the depth that the first and second directional dilators 30, 40 are inserted into the patient.


In addition, the first and second directional dilators, 30, 40 preferably include first and second grips 39, 49, respectively, located at the proximal ends 32, 42 thereof to better enable the surgeon to grip the dilators 30, 40 in use. The first and second grips 39, 49 may be utilized by the surgeon during insertion, removal, twisting or otherwise manipulating the first and second directional dilators 30, 40 during surgery.


As best shown in FIG. 1, the first directional dilator 30 preferably has a first length Li while the second directional dilator 40 has a second length L2. The first length Li is preferably greater than the second length L2 to facilitate handling and insertion. Similarly, the stimulating probe 20 preferably has a probe length L3 such that the probe length L3 is greater than the first length Li and the second length L2. The greater first length Li of the first directional dilator 30 permits the proximal end 33 of the first directional dilator 30 to extend further out of the patient in the assembled and operational configurations such that a surgeon may grasp the first grip 39 and remove or otherwise manipulate the first directional dilator 30 even after the second directional dilator 40 is inserted into the patient. In the first preferred embodiment, the first length is two hundred twenty millimeters (220 mm) and the second length is two hundred millimeters (200 mm), but are not so limited and may have nearly any length that permits insertion into the patient with the proximal ends 33, 43 extending out of the patient. In addition, the first directional dilator 30 preferably has a first diameter Di and the second directional dilator 40 has a second diameter D2, the second diameter D2 is preferably greater than the first diameter Dl. In the first preferred embodiment, the first diameter Di is approximately seven and seven tenths millimeters (7.7 mm) and the second diameter D2 is approximately seventeen and one-half millimeters (17.5 mm). However, the first and second diameters Di, D2 are not so limited and may have nearly any diameter desired by the surgeon for dilating tissue various distances from the stimulating probe 20. Further, the first and second directional dilators 30, 40 are not limited to having a circular cross-section and may have nearly any cross-section and be adapted to shapes that permits directional dilation in a manner that is preferred by a surgeon. For example, the first and second directional dilators 30, 40 may have an oval or oblong cross-sectional shape that urges dilation and a surgical working channel even further from a detected nerve 9 than a dilator having a circular cross-section.


A method of using the stimulating probe 20 and first and second directional dilators 30, 40 will now be described for accessing the patient's spine 2. The technique may be particularly desirable for accessing the lumbar region of the spine 2 via a lateral approach, although a similar or the same method may be used in other parts of the patient's body.


Using the stimulating probe 20 and a triggered electromyograph (EMG) 50, the surgeon preferably maps a safe zone, i.e., a zone generally free of any neural elements or nerves 9, on the tissue of interest (e.g., psoas muscle 4). For example, on the psoas muscle 4, the anterior third of the psoas muscle 4 is generally considered a safe zone.


Once a safe zone is established, anatomical placement is preferably confirmed via intra-operative fluoroscopy. The surgeon inserts the stimulating probe 20 through the psoas muscle 4 toward the patient's spine 2. If the surgery is being performed on the intervertebral disc space 6, the distal end of the stimulating probe 20 may be inserted into the annulus of the desired intervertebral disc space 6. Preferably, the stimulating probe 20 will be inserted via the most posterior portion of the safe zone.


The surgeon can insert or slide the first directional dilator 30 over the stimulating probe 20 so that the first longitudinal axis 31 is located to one side of the stimulating probe 20, preferably away from a sensed neural element or nerve 9, through the psoas muscle 4 and into a position proximate the patient's spine 2. The surgeon can then insert the second directional dilator 40, if necessary, to further dilate the tissue proximate the outside surface 32 of the first directional dilator 30 and further away from the sensed neural element or nerve 9. The surgeon can repeat this process as often as necessary. Finally, if desired, a retractor 60 can be inserted over the second directional dilator 40 to subsequently retract the tissue and to permit removal of the first and second directional dilators 30, 40 and the stimulating probe 20. Alternatively, a working cannula (not shown) may be inserted over the second dilator 40 such that a procedure on the spine 2 may be performed through the working cannula.


Additionally, if desired, before inserting the second directional dilator 40, the stimulating probe 20 can be removed from the first bore 35 and the dilator/probe combination rotated. Thereafter, using the triggered EMG stimulation 50, the surgeon can verify that the nerve root 9 is located at the expected side of the first directional dilator 30, preferably opposite the first channel 38. The stimulating probe 20 is preferably re-inserted into the first bore 35, before insertion of the second directional dilator 40.


By using the first and second directional dilators 30, 40, as compared to concentric sequential dilators as are generally known to those having skill in the art, the directional sequential dilation system 10 preferably ensures that the access opening is created away from the neural elements or nerves 9 of the psoas muscle 4, thus avoiding any neural elements or nerves 9 that may, for example, be located on the posterior side of the stimulating probe 20.


Moreover, the directional sequential dilation system 10 also reduces the amount of tissue damage when separating the tissue by minimizing the amount of tissue separation.


Alternatively, as shown in FIGS. 7-10, a one step blunt stimulating dilator 100 comprising a second preferred embodiment of a dilation system of the present application may be used. The blunt stimulating dilator 100 includes an outer surface 102, a proximal end 104, a distal end 106 and a bore 108 extending from the proximal end 104 to the distal end 106. The proximal end 104 includes an area 110 for attaching a stimulating clip or cord. The distal end 106 includes an exposed, preferably pointed tip 112 for delivering electrical stimulation. The outer surface 102 of the stimulating dilator 100 between the proximal and distal ends 104, 106 is preferably coated to prevent electrical leakage. The stimulating dilator 100 also preferably includes a channel 114 formed in the outer surface 102 thereof for receiving a stimulating probe, such as the stimulating probe 20 illustrated in FIG. 1. The stimulating probe can be any probe now or hereafter known for transmitting an electrical pulse.


The stimulating dilator 100 offers the surgeon the ability to simultaneously stimulate and dilate the psoas muscle 4. After placing the tip 112 of the stimulating dilator 100 into the disc space, the stimulating probe 20 can be inserted through the channel 114 along the outer surface 102 of the dilator 100 to stimulate the periphery of the dilated tissue.


Alternatively, as shown in FIGS. 11 and 12, the stimulating dilator 100′ comprised of a third preferred embodiment of the present application may include a plurality of channels 114 formed in the outer surface 102 thereof. For example, as shown, the stimulating dilator 100′ may include four channels 114a-d diametrically spaced on the outer surface 102 of the dilator 100′. In this manner, the surgeon can stimulate anterior, posterior, cranially, and caudally to verify the location of the nerve root once the dilator 100′ is in place. Although as will be understood by one of ordinary skill in the art, the stimulating dilator 100′ may include any number of channels 114 including, for example, two, three, five or more.


A method of using the blunt stimulating dilation system will now be described to produce access to the spine 2, in particular to provide an access opening through the psoas muscle 4 in the lumbar region of the spine 2 via a lateral approach. Although as will be understood by one of ordinary skill in the art, the method may be used in other parts of the body and utilizing alternative approaches.


In use, a surgeon inserts, preferably laterally, the blunt stimulating dilator 100, 100′ into the psoas 4 muscle via, for example, a twisting motion. The surgeon preferably uses a triggered EMG 50 to transmit an electrical pulse into the blunt stimulating dilator 100, 100′ in order to locate a safe zone in the patient's psoas muscle 4 by locating nerve roots 9. Once the location of any nerve root 9 has been confirmed to be posterior to the blunt stimulating dilator 100, 100′, the surgeon can laterally insert the blunt stimulating dilator 100, 100′ through the psoas muscle 4 and toward the patient's spine 2, preferably into the annulus of the disc space 6. The surgeon inserts or slides the stimulating probe 20 into the channel 114 formed in the outer surface 102 of the blunt stimulating dilator 100, 100′. If desired, the surgeon rotates the blunt stimulating dilator 100 with the stimulating probe 20 located in the channel 114 while using the EMG 50 to verify the location of the nerve root 9. Alternatively, in connection with the four channel blunt stimulating dilator 100′, rotation of the blunt stimulating dilator 100 is not required. Rather, the stimulating probe 20 can be independently inserted into each channel 114a-d to verify the location of the nerve root 9. The surgeon can then, if desired, insert a retractor over the stimulating dilator 100, 100′.


While the foregoing description and drawings represent the preferred embodiments of the present invention, it will be understood that various additions, modifications and substitutions may be made therein without departing from the spirit and scope of the present invention as defined in the accompanying claims. In particular, it will be clear to those skilled in the art that the present invention may be embodied in other specific forms, structures, arrangements, proportions, and with other elements, materials, and components, without departing from the spirit or essential characteristics thereof. One skilled in the art will appreciate that the invention may be used with many modifications of structure, arrangement, proportions, materials, and components and otherwise, used in the practice of the invention, which are particularly adapted to specific environments and operative requirements without departing from the principles of the present invention. In addition, features described herein may be used singularly or in combination with other features. The presently disclosed embodiments are therefore to be considered in all respects as illustrative and not restrictive, the scope of the invention being indicated by the appended claims, and not limited to the foregoing description.

Claims
  • 1. A method of forming an access opening through a psoas muscle to a patient's spine, comprising: (a) inserting a stimulating probe into the psoas muscle to locate a nerve and a safe zone in the psoas muscle, the stimulating probe having a probe axis and a probe tip;(b) inserting the stimulating probe through the psoas muscle so the probe tip is proximate the patient's spine;(c) obtaining a first directional dilator having a longitudinal axis, a bore with a length extending from a proximal end to a distal end, a bore axis that is offset from the longitudinal axis, and a channel formed in an outer surface thereof and extending from the proximal end to the distal end so as to be in communication with the bore along an entirety of the length of the bore;(d) inserting the first directional dilator through the psoas muscle and toward the patient's spine guided by sliding engagement of the stimulating probe with the bore of the first directional dilator and with the channel of the first directional dilator positioned between the nerve and the longitudinal axis of the first directional dilator;(e) obtaining a second directional dilator having a longitudinal axis, a bore with a length extending from a proximal end to a distal end, a bore axis that is offset from the longitudinal axis, and a channel formed in an outer surface thereof and extending from the proximal end to the distal end so as to be in communication with the bore along an entirety of the length of the bore; and(f) inserting the second directional dilator through the psoas muscle toward the patient's spine guided by sliding engagement of the first directional dilator with the bore of the second directional dilator and with the channel of the second directional dilator positioned between the nerve and the longitudinal axis of the second directional dilator.
  • 2. The method of claim 1, wherein in the step of inserting the first directional dilator, the bore axis of the first directional dilator is coaxial with the probe axis.
  • 3. The method of claim 1, wherein in the step of inserting the second directional dilator, the bore axis of the second directional dilator is coaxial with the longitudinal axis of the first directional dilator.
  • 4. The method of claim 1, wherein the first directional dilator has a first length and the second directional dilator has a second length, and wherein the first length is greater than the second length so the first directional dilator extends beyond the second directional dilator upon the second directional dilator being inserted through the psoas muscle.
  • 5. The method of claim 4, wherein the stimulating probe has a probe length that is greater than the first length so the stimulating probe extends beyond the first directional dilator upon the first directional dilator being inserted through the psoas muscle.
  • 6. The method of claim 1, wherein the channel of the first directional dilator is radially aligned with the channel of the second directional dilator when the stimulating probe is received in the bore of the first directional dilator and when the first directional dilator is received in the bore of the second directional dilator.
  • 7. The method of claim 1, further comprising the step of: inserting a retractor over the second directional dilator.
  • 8. The method of claim 1, further comprising the step of: confirming via intra-operative fluoroscopy the location of the safe zone prior to step (b).
  • 9. A method of forming an access opening through a psoas muscle to a patient's spine, comprising: (a) inserting a stimulating probe into the psoas muscle to locate a nerve and a safe zone in the psoas muscle, the stimulating probe having a probe axis and a probe tip;(b) inserting the stimulating probe through the psoas muscle so the probe tip is proximate the patient's spine;(c) obtaining a first directional dilator having a longitudinal axis, a bore with a length extending from a proximal end to a distal end, a bore axis that is offset from the longitudinal axis, and a channel formed in an outer surface thereof and extending from the proximal end to the distal end so as to be in communication with the bore along at least a portion of the length of the bore;(d) inserting the first directional dilator through the psoas muscle and toward the patient's spine guided by sliding engagement of the stimulating probe with the bore of the first directional dilator and with the channel of the first directional dilator positioned between the nerve and the longitudinal axis of the first directional dilator;(e) obtaining a second directional dilator having a longitudinal axis, a bore with a length extending from a proximal end to a distal end, a bore axis that is offset from the longitudinal axis of the second directional dilator, and a channel formed in an outer surface thereof and extending from the proximal end to the distal end so as to be in communication with the bore of the second directional dilator along at least a portion of the length of the bore of the second directional dilator; and(f) inserting the second directional dilator through the psoas muscle toward the patient's pine guided by sliding engagement of the first directional dilator with the bore of the second directional dilator and with the channel of the second directional dilator positioned between the nerve and the longitudinal axis of the second directional dilator.
  • 10. The method of claim 9, wherein in the step of inserting the first directional dilator, the bore axis of the first directional dilator is coaxial with the probe axis.
  • 11. The method of claim 9, wherein in the step of inserting the second directional dilator, the bore axis of the second directional dilator is coaxial with the longitudinal axis of the first directional dilator.
  • 12. The method of claim 9, wherein the first directional dilator has a first length and the second directional dilator has a second length, and wherein the first length is greater than the second length so the first directional dilator extends beyond the second directional dilator upon the second directional dilator being inserted through the psoas muscle.
  • 13. The method of claim 12, wherein the stimulating probe has a probe length that is greater than the first length so the stimulating probe extends beyond the first directional dilator upon the first directional dilator being inserted through the psoas muscle.
  • 14. The method of claim 9, wherein the channel of the first directional dilator is radially aligned with the channel of the second directional dilator when the stimulating probe is received in the bore of the first directional dilator and when the first directional dilator is received in the bore of the second directional dilator.
  • 15. The method of claim 9, further comprising the step of: inserting a retractor over the second directional dilator.
  • 16. The method of claim 9, further comprising the step of: confirming via intra-operative fluoroscopy the location of the safe zone prior to step (b).
CROSS-REFERENCE TO RELATED APPLICATIONS

This application is a continuation of U.S. patent application Ser. No. 16/266,191, filed on Feb. 4, 2019; which is a continuation of U.S. patent application Ser. No. 15/964,561, filed on Apr. 27, 2018, now U.S. Pat. No. 10,194,895; which is a continuation of U.S. patent application Ser. No. 15/680,433, filed on Aug. 18, 2017, now U.S. Pat. No. 9,974,533; which is a continuation of U.S. patent application Ser. No. 15/202,738, filed on Jul. 6, 2016, now U.S. Pat. No. 9,737,290; which is a continuation of U.S. patent application Ser. No. 12/681,671, filed on Apr. 5, 2010, now U.S. Pat. No. 9,387,009, issued on Jul. 12, 2016; which is a U.S. National Stage Entry of PCT/US08/78927, filed on Oct. 6, 2008; which claims the benefit of U.S. Provisional Application No. 60/977,882, filed on Oct. 5, 2007, entitled “ADJACENT OR LATERAL DILATOR AND METHOD OF USING THE SAME;” the entire contents of each being hereby expressly incorporated by reference herein.

US Referenced Citations (385)
Number Name Date Kind
2878701 Weersma Mar 1959 A
3698391 Mahony Oct 1972 A
4350151 Scott Sep 1982 A
4449532 Storz May 1984 A
4573448 Kambin Mar 1986 A
4646738 Trott Mar 1987 A
4678459 Onik et al. Jul 1987 A
4716901 Jackson et al. Jan 1988 A
4862891 Smith Sep 1989 A
4863430 Klyce et al. Sep 1989 A
4888146 Dandeneau Dec 1989 A
5071410 Pazell Dec 1991 A
5080662 Paul Jan 1992 A
5120318 Nallapareddy Jun 1992 A
5129906 Ross et al. Jul 1992 A
5152765 Ross et al. Oct 1992 A
5158543 Lazarus Oct 1992 A
5171279 Mathews Dec 1992 A
5195541 Obenchain Mar 1993 A
5241972 Bonati Sep 1993 A
5242443 Kambin Sep 1993 A
5285795 Ryan et al. Feb 1994 A
5357983 Mathews Oct 1994 A
5395317 Kambin Mar 1995 A
5439464 Shapiro Aug 1995 A
5472426 Bonati et al. Dec 1995 A
5480440 Kambin Jan 1996 A
5496322 Mathews Mar 1996 A
5520609 Moll et al. May 1996 A
5529580 Kusunoki et al. Jun 1996 A
5540706 Aust et al. Jul 1996 A
5545228 Kambin Aug 1996 A
5569248 Mathews Oct 1996 A
5569290 McAfee Oct 1996 A
5575176 Rohrs et al. Nov 1996 A
5580344 Hasson Dec 1996 A
5584887 Kambin Dec 1996 A
5591187 Dekel Jan 1997 A
5601569 Pisharodi Feb 1997 A
5662300 Michelson Sep 1997 A
5688222 Hluchy et al. Nov 1997 A
5728097 Mathews Mar 1998 A
5730754 Obenchain Mar 1998 A
5733242 Rayburn et al. Mar 1998 A
5735792 Vanden Hoek et al. Apr 1998 A
5741261 Moskovitz et al. Apr 1998 A
5762629 Kambin Jun 1998 A
5792044 Foley et al. Aug 1998 A
5820623 Ng Oct 1998 A
5885300 Tokuhashi et al. Mar 1999 A
5894369 Akiba et al. Apr 1999 A
5899425 Corey, Jr. et al. May 1999 A
5902231 Foley et al. May 1999 A
5910155 Ratcliff et al. Jun 1999 A
5954635 Foley et al. Sep 1999 A
5964698 Fowler Oct 1999 A
5964761 Kambin Oct 1999 A
5967970 Cowan et al. Oct 1999 A
5976146 Ogawa et al. Nov 1999 A
6033105 Barker et al. Mar 2000 A
6053907 Zirps Apr 2000 A
6063021 Hossain et al. May 2000 A
6099547 Gellman et al. Aug 2000 A
6110182 Mowlai-Ashtiani Aug 2000 A
6152871 Foley et al. Nov 2000 A
6159179 Simonson Dec 2000 A
6162170 Foley et al. Dec 2000 A
6175758 Kambin Jan 2001 B1
6200322 Branch et al. Mar 2001 B1
6234961 Gray May 2001 B1
6283966 Houfburg Sep 2001 B1
6286179 Byrne Sep 2001 B1
6296644 Saurat et al. Oct 2001 B1
6322498 Gravenstein et al. Nov 2001 B1
6336914 Gillespie, III Jan 2002 B1
6354992 Kato Mar 2002 B1
6360750 Gerber et al. Mar 2002 B1
6371968 Kogasaka et al. Apr 2002 B1
6383191 Zdeblick et al. May 2002 B1
6447446 Smith et al. Sep 2002 B1
6468289 Bonutti Oct 2002 B1
6520907 Foley et al. Feb 2003 B1
6558407 Ivando et al. May 2003 B1
6575899 Foley et al. Jun 2003 B1
6575979 Cragg Jun 2003 B1
6575987 Gellman et al. Jun 2003 B2
6579281 Palmer et al. Jun 2003 B2
6589225 Orth et al. Jul 2003 B2
6589262 Honebrink et al. Jul 2003 B1
6626830 Califiore et al. Sep 2003 B1
6637435 Ciaglia et al. Oct 2003 B2
6648915 Sazy Nov 2003 B2
6676597 Guenst et al. Jan 2004 B2
6679833 Smith et al. Jan 2004 B2
6688564 Salvermoser et al. Feb 2004 B2
6709389 Farascioni Mar 2004 B2
6758809 Briscoe et al. Jul 2004 B2
6793656 Mathews Sep 2004 B1
6808505 Kadan Oct 2004 B2
6887198 Phillips et al. May 2005 B2
6932765 Berg Aug 2005 B2
6983930 La Mendola et al. Jan 2006 B1
7008431 Simonson Mar 2006 B2
7079883 Marino et al. Jul 2006 B2
7087058 Cragg Aug 2006 B2
7104986 Hovda et al. Sep 2006 B2
7108698 Robbins et al. Sep 2006 B2
7137949 Scirica et al. Nov 2006 B2
7182731 Nguyen et al. Feb 2007 B2
7226413 McKinley Jun 2007 B2
7305989 Gostelow Dec 2007 B2
7341556 Shalman Mar 2008 B2
7434325 Foley et al. Oct 2008 B2
7435219 Kim Oct 2008 B2
7582058 Miles et al. Sep 2009 B1
7591790 Pflueger Sep 2009 B2
7594888 Raymond et al. Sep 2009 B2
7618431 Roehm, III et al. Nov 2009 B2
7636596 Solar Dec 2009 B2
7637905 Saadat et al. Dec 2009 B2
7641659 Emstad et al. Jan 2010 B2
7691057 Miles et al. Apr 2010 B2
7771384 Ravo Aug 2010 B2
7785253 Arambula et al. Aug 2010 B1
7794456 Sharps et al. Sep 2010 B2
7811303 Fallin et al. Oct 2010 B2
7931579 Bertolero et al. Apr 2011 B2
7935051 Miles et al. May 2011 B2
7946981 Cubb May 2011 B1
7951141 Sharps et al. May 2011 B2
7959564 Ritland Jun 2011 B2
RE42525 Simonson Jul 2011 E
7988623 Pagliuca et al. Aug 2011 B2
8005535 Gharib et al. Aug 2011 B2
8007492 DiPoto et al. Aug 2011 B2
8027716 Gharib et al. Sep 2011 B2
8038606 Otawara Oct 2011 B2
8043381 Hestad et al. Oct 2011 B2
8062218 Sebastian et al. Nov 2011 B2
8092464 McKay Jan 2012 B2
8096944 Harrel Jan 2012 B2
8114019 Miles et al. Feb 2012 B2
8202216 Melkent et al. Jun 2012 B2
8236006 Hamada Aug 2012 B2
8262571 Ritland Sep 2012 B2
8313430 Pimenta Nov 2012 B1
8333690 Ikeda Dec 2012 B2
8360970 Mangiardi Jan 2013 B2
8372131 Hestad et al. Feb 2013 B2
8382048 Nesper et al. Feb 2013 B2
8397335 Gordin et al. Mar 2013 B2
8435174 Cropper et al. May 2013 B2
8460180 Zarate et al. Jun 2013 B1
8460186 Ortiz et al. Jun 2013 B2
8460310 Stern Jun 2013 B2
8518087 Lopez et al. Aug 2013 B2
8535220 Mondschein Sep 2013 B2
8556809 Vijayanagar Oct 2013 B2
8585726 Yoon et al. Nov 2013 B2
8602979 Kitano Dec 2013 B2
8617062 Mire et al. Dec 2013 B2
8622894 Banik et al. Jan 2014 B2
8636655 Childs Jan 2014 B1
8690764 Clark et al. Apr 2014 B2
8702600 Perrow Apr 2014 B2
8721536 Marino et al. May 2014 B2
8740779 Yoshida Jun 2014 B2
8784421 Carrison et al. Jul 2014 B2
8821378 Morgenstern Lopez et al. Sep 2014 B2
8834507 Mire et al. Sep 2014 B2
8845734 Weiman Sep 2014 B2
8852242 Morgenstern Lopez et al. Oct 2014 B2
8870753 Boulais et al. Oct 2014 B2
8870756 Maurice Oct 2014 B2
8876712 Yee et al. Nov 2014 B2
8894573 Loftus et al. Nov 2014 B2
8894653 Solsberg et al. Nov 2014 B2
8926502 Levy et al. Jan 2015 B2
8932207 Greenburg et al. Jan 2015 B2
8932360 Womble et al. Jan 2015 B2
8936605 Greenberg Jan 2015 B2
8974381 Lovell et al. Mar 2015 B1
8986199 Weisenburgh, II et al. Mar 2015 B2
8992580 Bar et al. Mar 2015 B2
9028522 Prado May 2015 B1
9050146 Woolley et al. Jun 2015 B2
9055936 Mire et al. Jun 2015 B2
9072431 Adams et al. Jul 2015 B2
9078562 Poll et al. Jul 2015 B2
9131948 Fang et al. Sep 2015 B2
9144374 Maurice, Jr. Sep 2015 B2
9198674 Benson et al. Dec 2015 B2
9211059 Drach et al. Dec 2015 B2
9216016 Fiechter et al. Dec 2015 B2
9216125 Sklar Dec 2015 B2
9232935 Brand et al. Jan 2016 B2
9247997 Stefanchik et al. Feb 2016 B2
9265490 Bowman et al. Feb 2016 B2
9265491 Lins et al. Feb 2016 B2
9277928 Morgenstern Lopez Mar 2016 B2
9307972 Lovell et al. Apr 2016 B2
9320419 Kirma et al. Apr 2016 B2
RE46007 Banik et al. May 2016 E
RE46062 James et al. Jul 2016 E
9386971 Casey et al. Jul 2016 B1
9387009 Fatone et al. Jul 2016 B2
9387313 Culbert et al. Jul 2016 B2
9414828 Abidin et al. Aug 2016 B2
9486296 Mire et al. Nov 2016 B2
9492194 Morgenstern Lopez et al. Nov 2016 B2
9510853 Aljuri et al. Dec 2016 B2
9526401 Saadat et al. Dec 2016 B2
9579012 Vazales et al. Feb 2017 B2
9603510 Ammirati Mar 2017 B2
9603610 Richter et al. Mar 2017 B2
9610007 Kienzle et al. Apr 2017 B2
9610095 To Apr 2017 B2
9629521 Ratnakar Apr 2017 B2
9655605 Serowski et al. May 2017 B2
9655639 Mark May 2017 B2
9668643 Kennedy, II et al. Jun 2017 B2
9675235 Lieponis Jun 2017 B2
9700378 Mowlai-Ashtiani Jul 2017 B2
9706905 Levy Jul 2017 B2
9888911 Siegal Feb 2018 B2
20020022762 Beane et al. Feb 2002 A1
20020035373 Carlson et al. Mar 2002 A1
20020138020 Pflueger Sep 2002 A1
20030083555 Hunt et al. May 2003 A1
20030083688 Simonson May 2003 A1
20030171744 Leung et al. Sep 2003 A1
20030191474 Cragg et al. Oct 2003 A1
20030195405 Marino et al. Oct 2003 A1
20040059339 Roehm, III et al. Mar 2004 A1
20040093001 Hamada May 2004 A1
20040122446 Solar Jun 2004 A1
20040127992 Serhan et al. Jul 2004 A1
20040138662 Landry et al. Jul 2004 A1
20040143165 Alleyne Jul 2004 A1
20040147928 Landry et al. Jul 2004 A1
20040172022 Landry et al. Sep 2004 A1
20040225196 Ruane Nov 2004 A1
20050085692 Kiehn et al. Apr 2005 A1
20050090848 Adams Apr 2005 A1
20050149035 Pimenta et al. Jul 2005 A1
20050187570 Nguyen et al. Aug 2005 A1
20050256525 Culbert et al. Nov 2005 A1
20060004398 Binder, Jr. et al. Jan 2006 A1
20060106416 Raymond et al. May 2006 A1
20060195017 Shluzas et al. Aug 2006 A1
20060217754 Boehm, Jr. et al. Sep 2006 A1
20060247651 Roehm, III et al. Nov 2006 A1
20070055259 Norton et al. Mar 2007 A1
20070066977 Assell et al. Mar 2007 A1
20070073110 Larson et al. Mar 2007 A1
20070073111 Bass Mar 2007 A1
20070100212 Pimenta et al. May 2007 A1
20070129634 Hickey et al. Jun 2007 A1
20070149975 Oliver et al. Jun 2007 A1
20070156024 Frasier et al. Jul 2007 A1
20070198062 Miles et al. Aug 2007 A1
20070203396 McCutcheon et al. Aug 2007 A1
20070225556 Ortiz et al. Sep 2007 A1
20070260113 Otawara Nov 2007 A1
20070282171 Karpowicz et al. Dec 2007 A1
20080003325 Seaver Jan 2008 A1
20080015621 Emanuel Jan 2008 A1
20080021284 Hestad et al. Jan 2008 A1
20080033251 Araghi Feb 2008 A1
20080058606 Miles et al. Mar 2008 A1
20080081951 Frasier et al. Apr 2008 A1
20080188714 McCaffrey Aug 2008 A1
20080215081 Hsueh et al. Sep 2008 A1
20080319290 Mao et al. Dec 2008 A1
20090018566 Escudero et al. Jan 2009 A1
20090062871 Chin et al. Mar 2009 A1
20090105543 Miller et al. Apr 2009 A1
20090124860 Miles et al. May 2009 A1
20090156898 Ichimura Jun 2009 A1
20090187080 Seex Jul 2009 A1
20090240111 Kessler et al. Sep 2009 A1
20090259107 Crenshaw et al. Oct 2009 A1
20090287061 Feigenbaum et al. Nov 2009 A1
20090318765 Torii Dec 2009 A1
20100004651 Biyani Jan 2010 A1
20100022841 Takahashi et al. Jan 2010 A1
20100022845 Ott et al. Jan 2010 A1
20100076476 To et al. Mar 2010 A1
20100076502 Guyer et al. Mar 2010 A1
20100114147 Biyani May 2010 A1
20100151161 Da Rolo Jun 2010 A1
20100161060 Schaller et al. Jun 2010 A1
20100222644 Sebastian et al. Sep 2010 A1
20100256446 Raju Oct 2010 A1
20100280325 Ibrahim et al. Nov 2010 A1
20100284580 OuYang et al. Nov 2010 A1
20100286477 OuYang et al. Nov 2010 A1
20100312053 Larsen Dec 2010 A1
20100317989 Gharib et al. Dec 2010 A1
20110028791 Marino et al. Feb 2011 A1
20110054507 Batten et al. Mar 2011 A1
20110106261 Chin et al. May 2011 A1
20110125158 Diwan et al. May 2011 A1
20110130634 Solitario, Jr. et al. Jun 2011 A1
20110230782 Bartol et al. Sep 2011 A1
20110295070 Yasunaga Dec 2011 A1
20110319941 Bar et al. Dec 2011 A1
20120095296 Trieu et al. Apr 2012 A1
20120101338 O'Prey et al. Apr 2012 A1
20120209273 Zaretzka et al. Aug 2012 A1
20120221007 Batten et al. Aug 2012 A1
20120232350 Seex Sep 2012 A1
20120232552 Morgenstern Lopez et al. Sep 2012 A1
20120245431 Baudouin et al. Sep 2012 A1
20120298820 Manolidis Nov 2012 A1
20120316400 Vijayanagar Dec 2012 A1
20130103067 Fabro et al. Apr 2013 A1
20130103103 Mire et al. Apr 2013 A1
20130150670 O'Prey et al. Jun 2013 A1
20130150674 Haig et al. Jun 2013 A1
20130172676 Levy et al. Jul 2013 A1
20130261401 Hawkins et al. Oct 2013 A1
20130274557 Bowman et al. Oct 2013 A1
20130282022 Yousef Oct 2013 A1
20130289399 Choi et al. Oct 2013 A1
20130303846 Cybulski et al. Nov 2013 A1
20140066940 Fang et al. Mar 2014 A1
20140074170 Mertens et al. Mar 2014 A1
20140088367 DiMauro et al. Mar 2014 A1
20140128682 Loebl et al. May 2014 A1
20140135584 Lee et al. May 2014 A1
20140142584 Sweeney May 2014 A1
20140148647 Okazaki May 2014 A1
20140172002 Predick Jun 2014 A1
20140180321 Dias et al. Jun 2014 A1
20140194697 Seex Jul 2014 A1
20140215736 Gomez et al. Aug 2014 A1
20140257035 Blain Sep 2014 A1
20140257489 Warren et al. Sep 2014 A1
20140275799 Schuele Sep 2014 A1
20140275800 Miles et al. Sep 2014 A1
20140276840 Richter et al. Sep 2014 A1
20140277204 Sandhu Sep 2014 A1
20140318582 Mowlai-Ashtiani Oct 2014 A1
20140357945 Duckworth Dec 2014 A1
20150018623 Friedrich et al. Jan 2015 A1
20150051448 Hunt et al. Feb 2015 A1
20150065795 Titus Mar 2015 A1
20150073218 Ito Mar 2015 A1
20150112398 Morgenstern Lopez et al. Apr 2015 A1
20150164496 Karpowicz et al. Jun 2015 A1
20150216593 Biyani Aug 2015 A1
20150223676 Bayer et al. Aug 2015 A1
20150230697 Phee et al. Aug 2015 A1
20150342621 Jackson, III Dec 2015 A1
20150374213 Maurice, Jr. Dec 2015 A1
20160015467 Vayser et al. Jan 2016 A1
20160030061 Thommen et al. Feb 2016 A1
20160066965 Chegini et al. Mar 2016 A1
20160067003 Chegini et al. Mar 2016 A1
20160074029 O'Connell et al. Mar 2016 A1
20160095505 Johnson et al. Apr 2016 A1
20160106408 Ponmudi et al. Apr 2016 A1
20160166135 Fiset Jun 2016 A1
20160174814 Igov Jun 2016 A1
20160213500 Beger et al. Jul 2016 A1
20160228280 Schuele et al. Aug 2016 A1
20160235284 Yoshida et al. Aug 2016 A1
20160287264 Chegini et al. Oct 2016 A1
20160296220 Mast et al. Oct 2016 A1
20160353978 Miller et al. Dec 2016 A1
20170003493 Zhao Jan 2017 A1
20170007226 Fehling Jan 2017 A1
20170027606 Cappelleri et al. Feb 2017 A1
20170042408 Washburn et al. Feb 2017 A1
20170042411 Kang et al. Feb 2017 A1
20170065269 Thommen et al. Mar 2017 A1
20170065287 Silva et al. Mar 2017 A1
20170086939 Vayser et al. Mar 2017 A1
20170135699 Wolf May 2017 A1
20170156755 Poll et al. Jun 2017 A1
20170156814 Thommen et al. Jun 2017 A1
20170196549 Piskun et al. Jul 2017 A1
20170224391 Biester et al. Aug 2017 A1
20180271513 Perrow et al. Sep 2018 A1
Foreign Referenced Citations (35)
Number Date Country
102727309 Oct 2012 CN
9415039 Nov 1994 DE
29916026 Dec 1999 DE
0537116 Apr 1993 EP
0792620 Sep 1997 EP
0807415 Nov 1997 EP
1 340 467 Sep 2003 EP
2179695 Apr 2010 EP
2481727 Jan 2012 GB
2003169809 Jun 2003 JP
1996029014 Sep 1996 WO
2001056490 Aug 2001 WO
2001089371 Nov 2001 WO
2002002016 Jan 2002 WO
2004091426 Oct 2004 WO
2004103430 Dec 2004 WO
2005094695 Oct 2005 WO
2005096735 Oct 2005 WO
2007016368 Feb 2007 WO
2007087536 Aug 2007 WO
2008121162 Oct 2008 WO
2009033207 Mar 2009 WO
2011069036 Jun 2011 WO
2011112878 Sep 2011 WO
2013033426 Mar 2013 WO
2013059640 Apr 2013 WO
2014050236 Apr 2014 WO
2014100761 Jun 2014 WO
2014185334 Nov 2014 WO
2016111373 Jul 2016 WO
2016131077 Aug 2016 WO
2016168673 Oct 2016 WO
2017006684 Jan 2017 WO
2017015480 Jan 2017 WO
2017083648 May 2017 WO
Non-Patent Literature Citations (18)
Entry
International Search Report and Written Opinion (PCT/US08/78927) dated Jan. 14, 2009.
Adam Schriber, M.D., “Does Percutaneous Nucleotomy With Discoscopy Replace Conventional Discectomy?” Clinical Orthopedics and Related Research (1989).
Adam Schrieber, M.D., “Percutaneous Nucleotomy: Technique with Discoscopy,” Orthopedics (1991).
Hallett H. Matthews, M.D., “Percutaneous Interbody Fusions,” Spinal Fusion (1998).
Takatomo Moro, M.D. et al., “An Anatomic Study of the Lumbar Plexis with Respect to Retroperitoneal Endoscopic Surgery,” SPINE (28.5) pp. 423-428 (2003).
Partial European Search Report (EP13163266.3-1654); dated Jul. 12, 2013; 8 pages.
Extended European Search Report (EP13163266.3-1654); dated Oct. 30, 2013; 13 pages.
Invitation to pay fees (PCT/US16/50022), dated Nov. 3, 2016, 2 pages.
Percutaneous Transforaminal Endoscopic Disectomy: The Thessys Method; Menno Iprenburg; 17 pgs.
International Search Report and Written Opinion (PCT/US2015/043554) dated Nov. 19, 2015: 8 pgs.
International Search Report and Written Opinion (PCT/US2015/048485) dated Feb. 9, 2016; 16 pgs.
Invitation to Pay Fees (PCT/US2016/050022); dated Nov. 3, 2016; 2 pgs.
International Search Report and Written Opinion (PCT/US2015/060978) dated Feb. 15, 2016; 8 pgs.
International Search Report and Written Opinion (PCT/US2016/050022) dated Feb. 1, 2017; 19 pgs.
A hands-free region-of-interest selection interface for solo surgery with a wide-angle endoscope: preclinical proof of concept; Kyunghwa Jung; Published online Aug. 8, 2016; 7 pgs.
Maxcess XLIF Surgical Technique; Oct. 16, 2012; 30 pgs.
Mechanomyography is more sensitive than EMG in detecting age-related sarcopenia; Journal of Biomechanics; vol. 43, Issue 3; Feb. 10, 2010; pp. 551-556; 20 pgs.
Iprenburg, M, “Percutaneous Transforaminal Endoscopic Discectomy: The Thessys Method,” in Lewandrowski, K., et al., Minimally Invasive Spinal Fusion Techniques, Summit Communications, 2008 pp. 65-81.
Related Publications (1)
Number Date Country
20210169461 A1 Jun 2021 US
Provisional Applications (1)
Number Date Country
60977882 Oct 2007 US
Continuations (5)
Number Date Country
Parent 16266191 Feb 2019 US
Child 17181477 US
Parent 15964561 Apr 2018 US
Child 16266191 US
Parent 15680433 Aug 2017 US
Child 15964561 US
Parent 15202738 Jul 2016 US
Child 15680433 US
Parent 12681671 US
Child 15202738 US